VENETOCLAX for Acute myeloid leukaemia recurrent: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 558 adverse event reports in the FDA FAERS database where VENETOCLAX was used for Acute myeloid leukaemia recurrent.

Most Reported Side Effects for VENETOCLAX

Side Effect	Reports	%	Deaths	Hosp.
Death	9,412	17.5%	9,399	774
Off label use	6,252	11.6%	2,257	1,642
Neutropenia	3,041	5.7%	626	1,121
Febrile neutropenia	2,663	5.0%	665	1,725
Platelet count decreased	2,367	4.4%	311	1,357
Pyrexia	2,351	4.4%	487	1,834
Pneumonia	2,300	4.3%	790	1,683
Fatigue	2,281	4.3%	168	920
Diarrhoea	2,082	3.9%	278	964
White blood cell count decreased	1,913	3.6%	198	1,007
Myelosuppression	1,864	3.5%	84	756
Thrombocytopenia	1,834	3.4%	404	653
Nausea	1,814	3.4%	197	772
Infection	1,757	3.3%	460	912
Anaemia	1,671	3.1%	329	712